Gentherm Inc 8-K/A

What Happened Gentherm Inc. filed an 8‑K on April 23, 2026 disclosing a First Amendment (dated February 24, 2026) to its Second Amended and Restated Credit Agreement. The amendment is attached as Exhibit 10.1 to the filing and involves Gentherm Incorporated and certain subsidiaries as borrowers (Gentherm (Texas), Inc.; Gentherm Medical, LLC; Gentherm GmbH; Gentherm Präzision SE (f/k/a Alfmeier Präzision SE)), the lenders party thereto and Bank of America, N.A. as administrative agent. The filing also discloses planned SEC filings in connection with Gentherm’s proposed transaction with Modine Manufacturing Company and Modine’s Performance Technologies business (SpinCo).

Key Details

• Filing: Current Report on Form 8‑K filed April 23, 2026; First Amendment dated February 24, 2026 (Exhibit 10.1).
• Parties to amendment: Gentherm and listed subsidiaries as borrowers; lenders party thereto; Bank of America, N.A. as administrative agent.
• Exhibits: Certain schedules and exhibits to the amendment were omitted under Item 601(a)(5) of Regulation S‑K and will be furnished to the SEC upon request.
• Proposed Transaction disclosures: Gentherm and Modine intend to file a Form S‑4 (Gentherm) and a Form 10 (SpinCo) and will distribute a proxy statement/prospectus to Gentherm shareholders; filings and mailings will include more transaction details and require shareholder/regulatory approvals.

Why It Matters This 8‑K reports a material change to Gentherm’s financing documents and signals preparatory steps for the announced transaction with Modine/SpinCo. The credit‑agreement amendment and the planned S‑4/Form 10 filings are directly relevant to how the companies will disclose financing, transaction terms and related risks. Retail investors should watch for the upcoming proxy statement/prospectus and Form S‑4/Form 10 (to be filed with the SEC) for full details, financing terms, and the timing of any shareholder vote or closing conditions. The filing also includes standard forward‑looking statements and a list of risks that could affect completion of the proposed transaction.